Company Intelligence Profile

Symbio Generrics India Private Limited

Symbio Generrics India is a Bangalore-based pharma company making APIs, pharmaceutical enzymes and pre-formulations at three facilities.

CIN: U74990KA2011PTC184231ActiveRoC Karnataka

Last updated 28 October 2026

AI OverviewGenerated from public records

Symbio Generrics India Private Limited is a research-led pharmaceutical company based in Bangalore, Karnataka. It makes APIs, pharmaceutical enzymes and value-added pre-formulations, and offers contract research and manufacturing partnerships. The company was incorporated on 30 May 2011 and operates three facilities. Its revenue band for FY2023-24 was ₹300-400 Cr, and its bank charges total about ₹267.6 Cr.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Symbio Generrics India

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameSYMBIO GENERRICS INDIA PRIVATE LIMITED
CINU74990KA2011PTC184231
StatusActive
ListingUnlisted
Incorporated30 May 2011
ROCRoC Karnataka (Bangalore)
Sector (NIC)Pharma & Life Sciences (NIC 74990)
Registered addressSymbio House, No-1215, 24th Main, 11th Cross, HSR Layout 1st Sector, Bangalore, Karnataka 560102
Authorized capitalRs 3.1 Cr
Paid-up capitalRs 3.0 Cr

Business Overview

  • Symbio Generrics India Private Limited is a research-led pharmaceutical development and manufacturing company.
  • It sells APIs, pharmaceutical enzymes and value-added pre-formulations.
  • It also offers contract research, development and manufacturing partnerships.
  • It was incorporated on 30 May 2011 and is headquartered in Bangalore, Karnataka.

Directors

NameDINRoleAppointed
Akash Suresh Puranik06775891Managing Director-
Salim Sadiq Shaikh03398407Whole-time Director-
Sharma Natraj Kannan00408118Director-
Deepak Komaregowda03298261Nominee Director-

Financials

FY2023-24
  • Revenue band ₹300-400 Cr

Charges & Borrowings

  • Bank charges total about ₹267.6 Cr.
  • Lenders include Axis Bank, ICICI Bank, Kotak Mahindra Bank, CitiBank, SBI Factors, Bank of Baroda and HDFC Bank.

Frequently Asked Questions

What does SYMBIO GENERRICS INDIA PRIVATE LIMITED do?
It is a research-led pharmaceutical company. It makes APIs, pharmaceutical enzymes and value-added pre-formulations, and offers contract research, development and manufacturing partnerships.
Who are the directors of SYMBIO GENERRICS INDIA PRIVATE LIMITED?
The directors are Akash Suresh Puranik (Managing Director), Salim Sadiq Shaikh (Whole-time Director), Sharma Natraj Kannan (Director) and Deepak Komaregowda (Nominee Director).
When was SYMBIO GENERRICS INDIA PRIVATE LIMITED incorporated?
The company was incorporated on 30 May 2011 as an unlisted private limited company.
What is the CIN of SYMBIO GENERRICS INDIA PRIVATE LIMITED?
The CIN is U74990KA2011PTC184231.
Where is SYMBIO GENERRICS INDIA PRIVATE LIMITED registered?
It is registered with the RoC Karnataka (Bangalore). The registered office is in HSR Layout, Bangalore, Karnataka 560102.

Recur Market

Which lenders fit a company like Symbio Generrics India Private Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Similar Pharma & Life Sciences companies

More on Recur Club

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.